Asterias Biotherapeutics, Inc. (NASDAQ:AST) Files An 8-K Regulation FD Disclosure

On November 17, 2016, Asterias Biotherapeutics, Inc. (the
Company) posted a PowerPoint presentation on its website to
utilize for investor relation purposes. The presentation is
furnished herewith as Exhibit 99.1.

The information in this Item 7.01 and Item 9.01(d) is being
furnished and shall not be deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to the liabilities of
that section, nor shall such exhibits be deemed incorporated by
reference in any filing made by the Company under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such a filing.

Item 9.01 Financial Tables and Exhibits.

(d)

Exhibits.